JOHN MICHAEL LEWIS
Osteopathic Medicine in Norristown, PA
License number
Pennsylvania OT011849
Category
Osteopathic Medicine
Type
Graduate Osteopathic Trainee
Address
Address
Norristown, PA 19401
Personal information
See more information about JOHN MICHAEL LEWIS at radaris.comName
Address
Phone
5040 W Ridge Rd APT 503, Erie, PA 16506
498 W 5Th St, Williamstown, PA 17098
4 W Wayne St, Warren, PA 16365
500 Grandview Rd, Ellwood City, PA 16117
51 Elliott Dr, Northumberland, PA 17857
Professional information
John Lewis - East Norriton, PA
Work:
Logan Funeral Home
Funeral Assistant Lorel Marketing Group LLC
Senior Corporate Accountant Martins Run Lifecare Retirement Community - Newtown Square, PA
Controller / Office Manager Community Services - Paoli, PA
Senior Accountant White Horse Village Retirement Community - Edgemont, PA
Staff Accountant - Receivables
Funeral Assistant Lorel Marketing Group LLC
Senior Corporate Accountant Martins Run Lifecare Retirement Community - Newtown Square, PA
Controller / Office Manager Community Services - Paoli, PA
Senior Accountant White Horse Village Retirement Community - Edgemont, PA
Staff Accountant - Receivables
Education:
West Chester University - West Chester, PA
B.S. in Accounting
B.S. in Accounting
Polynucleotide Herpes Virus Vaccine
US Patent:
7094767, Aug 22, 2006
Filed:
Apr 16, 2001
Appl. No.:
09/835699
Inventors:
Marcy E. Armstrong - Schwenksville PA, US
Robert D. Keys - Norristown PA, US
John A. Lewis - Norristown PA, US
Margaret A. Liu - Rosemont PA, US
William L. McClements - Doylestown PA, US
Robert D. Keys - Norristown PA, US
John A. Lewis - Norristown PA, US
Margaret A. Liu - Rosemont PA, US
William L. McClements - Doylestown PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 48/00
US Classification:
514 44, 4353201
Abstract:
Genes encoding herpes simplex virus type 2 (HSV-2) proteins were cloned into eukaryotic expression vectors to express the encoded proteins in mammalian muscle cells in vivo. Animals were immunized by injection of these DNA constructs, termed polynucleotide vaccines or PNV, into their muscles. In a DNA titration, it was found that a single immunization of ≧0. 5 μg of (one) PNV, gave >90% seroconversion by ten weeks post immunization. Immune antisera neutralized both HSV-2 and HSV-1 in cell culture. When animals were challenged with HSV-2, significant (p